Target intelligence / Profile preview

Signal transducer and activator of transcription protein (STAT protein) (STAT)

Target
STAT
Molecular classification
Transcription factor, DNA-binding protein, Signal transduction molecule
01

Overview

The Signal transducer and activator of transcription proteins (STAT proteins) constitute a family of intracellular transcription factors that mediate critical aspects of cellular immunity, proliferation, apoptosis, and differentiation. There are seven mammalian members—STAT1, STAT2, STAT3, STAT4, STAT5A/B, and STAT6—all sharing a conserved structure with domains for dimerization (N-terminal and SH2), nuclear localization (coiled-coil), DNA binding (DNA-binding domain), and transcriptional activation (C-terminal domain). Activation occurs when cytokines or growth factors bind to their receptors on the cell surface. This triggers associated Janus kinases to phosphorylate specific tyrosine residues on the receptor as well as on the cytoplasmic tail of nearby STAT proteins. Phosphorylated STATs dimerize via their SH2 domains and then translocate into the nucleus where they bind specific DNA motifs to regulate gene expression. Unphosphorylated forms can also shuttle between cytoplasm and nucleus with regulatory functions still being elucidated. The JAK/STAT pathway is central to many biological processes including hematopoiesis; immune cell maturation; inflammation regulation; bone development; cellular growth control; migration; survival/apoptosis decisions; allergic responses; among others. Dysregulation or mutation—especially gain-of-function mutations—of certain family members like STAT3 is implicated in various cancers as well as autoimmune diseases due to unchecked cell proliferation or impaired apoptosis.

Other names
STAT proteinSignal transducer and activator of transcriptionSTAT family memberJAK/STAT pathway component
02

Mechanism of action

Generally involves inhibition of phosphorylation, dimerization, or DNA binding activity.

03

Biological functions

Signal transductionRegulation of gene expressionCell proliferationApoptosis (cell death)Immune responseCell differentiation
04

Disease associations

Cancer (e.g., large granular lymphocytic leukemia, other malignancies)InflammationAutoimmune disease (e.g., rheumatoid arthritis, autoimmune hemolytic anemia)Infection/host defense impairment
05

Safety considerations

Immune suppressionOff-target effects due to broad roles in cell signaling
06

Interacting drugs

Small molecule inhibitors (under investigation)

Beyond the preview

Go deeper on Signal transducer and activator of transcription protein (STAT protein) (STAT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Signal transducer and activator of transcription protein (STAT protein) (STAT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call